Literature DB >> 31084912

Maternal and placental risk factors associated with the development of necrotizing enterocolitis (NEC) and its severity.

Miriam Duci1, Anna Chiara Frigo2, Silvia Visentin3, Giovanna Verlato4, Piergiorgio Gamba1, Francesco Fascetti-Leon5.   

Abstract

BACKGROUND/
PURPOSE: Antenatal factors play an important role in NEC. This study aimed to identify antenatal risk factors associated with the development of NEC, the role of the placental alterations, and the presence of prenatal signs predisposing to a severe NEC. MATERIALS/
METHODS: Data of NEC patients including antenatal findings [preeclampsia, diabetes, cholestasis, abnormal antenatal umbilical artery flow (AAUF), clinical chorioamnionitis (CC), and histology of placentas] were compared to unaffected cases between 2002 and 2016 in a single center. Unaffected infants were matched for gestational age. Newborns with cardiovascular diseases were excluded. Bivariate and multivariate analyses were performed.
RESULTS: We identified 136 cases and 134 controls. The group of mothers of NEC-neonates had a higher prevalence of preeclampsia, CC, and AAUF. Histology of Placentas from 123/136 cases and 126/133 unaffected newborns was available. Chorioamnionitis was significantly more present in NEC cases vs controls. There weren't differences in vascular anomalies and necrotic alterations. Multivariate analysis identified AAUF, CC and histological chorioamnionitis (HC) as predictors of NEC. Bivariate tests show that preeclampsia and HC occurred more often in severe cases of NEC.
CONCLUSION: This study suggests that AAUF, CC, and HC can independently predict the risk of NEC. Preeclampsia and HC seem associated to more severe cases. LEVEL OF EVIDENCE: IIIA.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Maternal risk factors; Necrotizing enterocolitis; Placental risk factors; Premature; Prognostic factors

Year:  2019        PMID: 31084912     DOI: 10.1016/j.jpedsurg.2019.04.018

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  [Influence of premature rupture of membranes on the early prognosis of extremely premature infants].

Authors:  Su-E Zhang; Xue-Yu Chen; Chun Chen; Xiao-Mei Qiu; Bing-Chun Lin; Chuan-Zhong Yang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

2.  Necrotizing Enterocolitis and Its Predictors Among Preterm Neonates Admitted in Neonatal Intensive Care Units of Gurage Zone Public Hospitals, Southwest Ethiopia, 2021.

Authors:  Bogale Chekole Temere; Agerie Aynalem Mewahegn; Bitew Tefera Zewudie; Fisha Alebel GebreEyesus; Amare Kassaw; Belete Gelaw Walle; Shegaw Geze Tenaw; Yibeltal Mesfin; Muche Argaw; Haymanot Abebe; Shegaw Tesfa; Netsanet Habte; Robel Birhanu; Wesila Seid
Journal:  Pediatric Health Med Ther       Date:  2022-03-30

3.  Case report: necrotizing enterocolitis with a transverse colonic perforation in a 2-day old term neonate and literature review.

Authors:  Jo-Anna Hudson; Simon Byrns; Elizabeth Nizalik; Emanuela Ferretti
Journal:  Matern Health Neonatol Perinatol       Date:  2021-01-07

4.  Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis.

Authors:  Peng Lu; Chhinder P Sodhi; Yukihiro Yamaguchi; William B Fulton; Sanxia Wang; Qinjie Zhou; Hongpeng Jia; Mark L Kovler; Andres Gonzalez Salazar; Maame Sampah; Thomas Prindle; Peter Wipf; David J Hackam
Journal:  Nat Commun       Date:  2021-02-15       Impact factor: 14.919

Review 5.  Optimizing Nutritional Strategies to Prevent Necrotizing Enterocolitis and Growth Failure after Bowel Resection.

Authors:  Laura Moschino; Miriam Duci; Francesco Fascetti Leon; Luca Bonadies; Elena Priante; Eugenio Baraldi; Giovanna Verlato
Journal:  Nutrients       Date:  2021-01-24       Impact factor: 5.717

6.  Fetal Doppler Evaluation to Predict NEC Development.

Authors:  Miriam Duci; Erich Cosmi; Pierpaolo Zorzato; Ambrogio Pietro Londero; Giovanna Verlato; Eugenio Baraldi; Eugenio Ragazzi; Francesco Fascetti Leon; Silvia Visentin
Journal:  J Pers Med       Date:  2022-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.